Allergy Treatment Market Report by Type (Eye Allergy, Skin Allergy, Food Allergy, Asthma, Rhinitis, and Others), Treatment (Anti-Allergy Drugs, Immunotherapy), Dosage Form (Oral, Inhalers, Intranasal, and Others), Distribution Channel (Hospital Pharmacies

Allergy Treatment Market Report by Type (Eye Allergy, Skin Allergy, Food Allergy, Asthma, Rhinitis, and Others), Treatment (Anti-Allergy Drugs, Immunotherapy), Dosage Form (Oral, Inhalers, Intranasal, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Retailers, and Others), and Region 2024-2032

The global allergy treatment market size reached US$ 22.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 35.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

Allergy treatment is a preventive medical cure for abnormal reactions to allergens, such as pollens, molds, animal dander, latex, insects, food, and medications. They trigger the release of histamine by the immune system that causes inflammation, rashes, itchiness, sneezing, runny nose, and red eyes. They can also cause various allergic conditions, including hay fever, asthma, rhinitis, and skin, food, and eye allergies. Allergy treatment includes anti-allergic drugs and immunotherapy that can be administered through oral, inhalers, and intranasal dosage forms. These treatment methods help reduce sensitivity and inflammation, decrease symptoms, and improve the quality of the patient’s life.

Allergy Treatment Market Trends:
The increasing prevalence of various allergies across the globe is one of the primary factors driving the market growth. In line with this, favorable initiatives by governments and non-governmental organizations (NGOs) to sensitize the masses about the adversities of allergies and their appropriate treatment options are favoring the market growth. Furthermore, increasing demand for over-the-counter (OTC) drugs, coupled with a growing inclination toward self-medication among consumers, is acting as another growth-inducing factor. Additionally, the integration of artificial intelligence (AI), natural language processing (NLP), and machine learning (ML) for diagnosing allergic diseases, predicting patient outcomes for targeted interventions, analyzing immunological data, and improving care delivery is providing an impetus to market growth. Apart from this, the increasing demand for subcutaneous allergen-specific immunotherapy (SCIT) due to its effectiveness, safety, and ability to alter the immune system and provide systemic relief is creating a positive outlook for the market. Other factors, including significant healthcare expenditures, increasing geriatric population, extensive research and development (R&D) activities towards novel treatments, and rising incidences of asthma, are anticipated to drive the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, treatment, dosage form and distribution channel.

Breakup by Type:

Eye Allergy
Skin Allergy
Food Allergy
Asthma
Rhinitis
Others

Breakup by Treatment:

Anti-Allergy Drugs
Immunotherapy

Breakup by Dosage Form:

Oral
Inhalers
Intranasal
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Retailers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., ALK-Abelló A/S, Allergopharma (Dermapharm AG), Allergy Therapeutics, Almirall S.A, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, HAL Allergy Group (Droege International Group), Leti Pharma, Nicox S.A., Sanofi S.A. and Stallergenes Greer.

Key Questions Answered in This Report

1. What was the size of the global allergy treatment market in 2023?
2. What is the expected growth rate of the global allergy treatment market during 2024-2032?
3. What are the key factors driving the global allergy treatment market?
4. What has been the impact of COVID-19 on the global allergy treatment market?
5. What is the breakup of the global allergy treatment market based on the type?
6. What is the breakup of the global allergy treatment market based on the treatment?
7. What are the key regions in the global allergy treatment market?
8. Who are the key players/companies in the global allergy treatment market?